Found: 3
Select item for more details and to access through your institution.
Retraction Note: Rifaximin alters gut microbiota profile, but does not affect systemic inflammation - a randomized controlled trial in common variable immunodeficiency.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-54117-6
- By:
- Publication type:
- Article
Rifaximin alters gut microbiota profile, but does not affect systemic inflammation - a randomized controlled trial in common variable immunodeficiency.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. 1, doi. 10.1038/s41598-018-35367-7
- By:
- Publication type:
- Article
The mitochondrial DNA constitution shaping T-cell immunity in patients with rectal cancer at high risk of metastatic progression.
- Published in:
- Clinical & Translational Oncology, 2022, v. 24, n. 6, p. 1157, doi. 10.1007/s12094-021-02756-w
- By:
- Publication type:
- Article